Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Apr;21 Suppl 1(0 1):18-25.
doi: 10.1111/iju.12308.

Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis

Affiliations
Review

Bladder afferent hyperexcitability in bladder pain syndrome/interstitial cystitis

Naoki Yoshimura et al. Int J Urol. 2014 Apr.

Abstract

Bladder pain syndrome/interstitial cystitis is a disease with lower urinary tract symptoms, such as bladder pain and urinary frequency, which results in seriously impaired quality of life of patients. The extreme pain and urinary frequency are often difficult to treat. Although the etiology of bladder pain syndrome/interstitial cystitis is still not known, there is increasing evidence showing that afferent hyperexcitability as a result of neurogenic bladder inflammation and urothelial dysfunction is important to the pathophysiological basis of symptom development. Further investigation of the pathophysiology will lead to the effective treatment of patients with bladder pain syndrome/interstitial cystitis.

Keywords: afferent pathway; bladder pain syndrome; cytokine; interstitial cystitis; nerve growth factor.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

None declared.

Figures

Fig. 1
Fig. 1
Proposed pathogenesis of BPS/IC.
Fig. 2
Fig. 2
Summary of the events involved in chronic inflammation of the bladder and hyperexcitability of C-fiber bladder afferent pathways. The events that occur after chronic bladder inflammation (1) are shows in sequential numbers (2–5). Potential therapeutic modalities targeting enhanced synaptic transmission at the spinal cord level or inflammatory changes in the bladder are also shown in the boxes.

Similar articles

Cited by

References

    1. Chancellor MB, Yoshimura N. Treatment of interstitial cystitis. Urology. 2004;63(3 Suppl 1):85–92. - PubMed
    1. Homma Y, Ueda T, Ito T, Takei M, Tomoe H. Japanese guideline for diagnosis and treatment of interstitial cystitis. Int. J. Urol. 2009;16:4–16. - PubMed
    1. Hanno PM, Burks DA, Clemens JQ, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J. Urol. 2011;185:2162–2170. - PMC - PubMed
    1. Parsons CL, Benson G, Childs SJ, Hanno P, Sant GR, Webster G. A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J. Urol. 1993;150:845–848. - PubMed
    1. Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L., Jr The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J. Urol. 1999;161:553–557. - PubMed

Publication types

MeSH terms